JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB66400

Anti-CD82 antibody

5

(4 Reviews)

|

(15 Publications)

Rabbit Polyclonal CD82 antibody. Suitable for WB, IHC-P and reacts with Human samples. Cited in 15 publications.

View Alternative Names

CD82, KAI1, SAR2, ST6, TSPAN27, CD82 antigen, C33 antigen, IA4, Inducible membrane protein R2, Metastasis suppressor Kangai-1, Suppressor of tumorigenicity 6 protein, Tetraspanin-27, Tspan-27

4 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD82 antibody (AB66400)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD82 antibody (AB66400)

ab66400 (1 : 80) staining CD82 in paraffin-embedded human tonsil tissue (left panel) using an automated system (Ventana Discovery). Right hand panel shows negative control (no primary antibody).
Using this protocol there is strong membrane staining of follicular dendritic cells, and the FDC network forming the structure of germinal centres is clearly highlighted by this antibody. There is associated weak staining of smaller cells in the interfollicar areas which may be T cells.

Sections were rehydrated and antigen retrieved in CC1 Cell Conditioning Buffer using Ventana Standard Retrieval programme. Slides were blocked in 3% H2O2 / 4 min / 37°C and incubated with ab66400 (1 : 80 dilution / 1 hour / 37°C). Sections then blocked (4mins / 37°C) and incubated with Dako swine anti-rabbit antibody (1 : 50, 28 min / 37°C). Staining was amplified and detected by incubation with Ventana Streptavidin ABC system (16 min / 37°

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD82 antibody (AB66400)
  • IHC-P

AbReview17988****

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD82 antibody (AB66400)

ab66400 (1/50) staining CD82 in paraffin-embedded Mouse salivary gland tissue. Tissue underwent fixation in formaldehyde, peroxidase blocking, protein blocking and heat mediated antigen retrieval. The secondary antibody was goat anti rabbit/mouse conjugated to HRP. For further experimental details please refer to abreview.

This image is courtesy of an abreview submitted by Antibody Solutions Ltd.

Western blot - Anti-CD82 antibody (AB66400)
  • WB

Project

Western blot - Anti-CD82 antibody (AB66400)

CD82 contains a number of potential glycosylation sites (SwissProt) which may explain its migration at a higher molecular weight than predicted.

All lanes:

Western blot - Anti-CD82 antibody (ab66400) at 1 µg/mL

All lanes:

Human brain tissue lysate - total protein (<a href='/en-us/products/unavailable/human-brain-tissue-lysate-total-protein-ab29466'>ab29466</a>) at 10 µg

Secondary

All lanes:

Goat polyclonal to Rabbit IgG - H&L - Pre-Adsorbed (HRP) at 1/3000 dilution

Predicted band size: 29 kDa

Observed band size: 34 kDa

false

Exposure time: 2min

Western blot - Anti-CD82 antibody (AB66400)
  • WB

CiteAb

Western blot - Anti-CD82 antibody (AB66400)

CD82 western blot using anti-CD82 antibody ab66400. Publication image and figure legend from Zhang, Q., Tan, D., et al., 2012, PLoS One, PubMed 22679510.

ab66400 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab66400 please see the product overview.

Expression of CD82 in human placental villi and cell lines.(A) Immunostaining of CD82 in normal human placental villi in the first trimester, maternal decidua, second trimester and third trimester. (a) CD82 was strongly expressed in trophoblast columns (TC) and moderate in CTB of human placental villi during the first trimester. (c) CD82 was highly expressed in decidual cells (DC). (e) CD82 was highly expressed in the maternal decidua, not detected in EVT and very faint in anchoring villous during the early second trimester. Boxed region is enlarged on the upper panel. (g) CD82 was absent in villous and very faint in EVT during the late second trimester. (i) CD82 was moderate expressed in cytotrophoblast cells invaded into the maternal decidua and highly expressed in syncytiotrophoblast in the third trimester. (b, f, h, j) Immunohistochemical staining with anti-cytokeratin7 (CK7) as a marker of CTB, TC in the first trimester placental vill, EVT in the maternal decidua; (d) Immunohistochemical staining with anti-vimentin as a maker of decidual cells. (k, l, m, n) negative controls (NEG) on sections in which normal IgG was used in place of primary antibody. CTB : cytotrophoblast; STB : syncytiotrophoblast; TC : trophoblast column; EVT : extravillous trophoblast; MD : maternal decidua, AV : anchoring villous W : weeks of pregnancy; Bar represents 100 µm. (B) Expression of CD82 in different trophoblast cell lines determined by semiquantitative RT-PCR and Western blot, respectively. GAPDH was used as an internal control for RT-PCR or loading control for Western blot. HTR8/SVneo : a human invasive extravillous trophoblast cell line derived from immortalized first trimester trophoblast; B6Tert : immortalized cytotrophoblast cell line; JEG-3 : human choriocarcinoma cell lines. (C) Immunofluorescence of CD82 in HTR8/SVneo cell lines. Fluorescence signals specific to CD82 antibody were visualized as green, and the nuclei were shown by DAPI staining (blue).

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB, IHC-P

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1 µg/mL", "WB-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/50 - 1/80", "IHCP-species-notes": "<p></p>" }, "Cow": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

CD82 also known as KAI1 is a member of the tetraspanin family of proteins. It has a molecular mass of approximately 29 to 30 kDa. This protein is widely expressed on the surface of various cell types such as epithelial cells lymphocytes and endothelial cells. It features four transmembrane domains implying a role in organizing membrane microdomains. CD82 is known for its role in promoting cell adhesion and motility through its involvement in protein-protein interactions on the cell surface.
Biological function summary

CD82 plays a significant role in regulating cell signaling and communication during tumor progression and metastasis. It participates in the formation of tetraspanin-enriched microdomains by associating with other tetraspanins and integrins influencing the cellular microenvironment. Additionally CD82 impacts immune cell interactions by modulating activities of T cells and B cells. Despite not being the predominant component in any major protein complex CD82 influences many cellular processes by regulating diverse signaling pathways.

Pathways

CD82 modulates both the PI3K-Akt signaling pathway and the Wnt signaling pathway. These pathways are critical in controlling cellular processes like growth and survival contributing to the metastasis-suppressive effects of CD82. In these contexts CD82 associates with proteins such as integrins and cadherins which facilitate its regulation of signal transduction and cellular dynamics. CD82's role in these pathways shows its importance in controlling cancer cell behavior and immune system interactions.

CD82 has been linked to various cancers particularly prostate cancer and melanoma. Its downregulation or loss often correlates with tumor progression and metastasis indicating its function as a metastasis suppressor. In cancer CD82 interacts with proteins like epidermal growth factor receptor (EGFR) and other integrins affecting disease progression by altering cell adhesion migration and invasion. CD82’s expression level serves as a potential biomarker for cancer prognosis and treatment outcomes.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Structural component of specialized membrane microdomains known as tetraspanin-enriched microdomains (TERMs), which act as platforms for receptor clustering and signaling (PubMed : 19497983). Participates thereby in diverse biological functions such as cell signal transduction, adhesion, migration and protein trafficking. Acts as a attenuator of EGF signaling, facilitating ligand-induced endocytosis of the receptor and its subsequent desensitization (PubMed : 10985391, PubMed : 35538033). Mechanistically, modulates ligand-induced ubiquitination and trafficking of EGFR via E3 ligase CBL phosphorylation by PKC (PubMed : 23897813). Increases cell-matrix adhesion by regulating the membrane organization of integrin alpha4/ITA4 (PubMed : 24623721, PubMed : 8757325). Modulates adhesion and suppresses cell migration through other integrins such as the alpha6/ITGA6 and beta1/ITGB1 (PubMed : 15557282, PubMed : 17560548). Decreases cell-associated plasminogen activation by interfering with the interaction between urokinase-type plasminogen activator/PLAU and its receptor PLAUR (PubMed : 15677461). Associates with CD4 or CD8 and delivers costimulatory signals for the TCR/CD3 pathway. Plays a role in TLR9 trafficking to acidified CpG-containing compartments by controlling interaction between TLR9 and VAMP3 and subsequent myddosome assembly (By similarity). Inhibits LPS-induced inflammatory response by preventing binding of LPS to TLR4 on the cell surface (PubMed : 36945827). Plays a role in the activation of macrophages into anti-inflammatory phenotypes (By similarity). Independently of Toll-like receptor (TLR) signaling, is recruited to pathogen-containing phagosomes prior to fusion with lysosomes and thereby participates in antigen presentation (By similarity). Also acts to control angiogenesis and switch angiogenic milieu to quiescent state by binding and sequestering VEGFA and PDGFB to inhibit the signaling they trigger via their respective cell surface receptor (PubMed : 34530889).
See full target information CD82

Publications (15)

Recent publications for all applications. Explore the full list and refine your search

JCI insight 10: PubMed40401524

2025

Endothelial extracellular vesicle miR-423-5p regulates microvascular homeostasis and renal function after ischemia-reperfusion injury.

Applications

Unspecified application

Species

Unspecified reactive species

Francis Migneault,Hyunyun Kim,Alice Doreille,Shanshan Lan,Alexis Gendron,Marie-Hélène Normand,Annie Karakeussian Rimbaud,Martin Dupont,Isabelle Bourdeau,Éric Bonneil,Julie Turgeon,Sylvie Dussault,Pierre Thibault,Mélanie Dieudé,Éric Boilard,Alain Rivard,Héloïse Cardinal,Marie-Josée Hébert

Current issues in molecular biology 46:1799-1809 PubMed38534734

2024

A Potential Role of CD82/KAI1 during Uterine Decidualization in Mice.

Applications

Unspecified application

Species

Unspecified reactive species

Qijun Li,Mengyao Song,Ke Cao,Qian Zhang

International journal of molecular sciences 25: PubMed38473906

2024

Tetraspanin CD82 Correlates with and May Regulate S100A7 Expression in Oral Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Kiran Kumar Reddi,Weiqiang Zhang,Shokoufeh Shahrabi-Farahani,Kenneth Mark Anderson,Mingyue Liu,David Kakhniashvili,Xusheng Wang,Yanhui H Zhang

Histochemistry and cell biology 159:163-183 PubMed36242635

2022

Distribution of tetraspanins in bovine ovarian tissue and fresh/vitrified oocytes.

Applications

Unspecified application

Species

Unspecified reactive species

Jana Jankovičová,Petra Sečová,Ľubica Horovská,Lucia Olexiková,Linda Dujíčková,Alexander V Makarevich,Katarína Michalková,Jana Antalíková

Acta biochimica et biophysica Sinica 54:400-408 PubMed35538033

2022

CD82 palmitoylation site mutations at Cys5+Cys74 affect EGFR internalization and metabolism through recycling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Jingya Bu,Weiliang Zhong,Meixian Li,Shuiqing He,Mingzhe Zhang,Yu Zhang,Ying Li

Cell death & disease 13:145 PubMed35149669

2022

Autolysosomes and caspase-3 control the biogenesis and release of immunogenic apoptotic exosomes.

Applications

Unspecified application

Species

Unspecified reactive species

Déborah Beillevaire,Francis Migneault,Julie Turgeon,Diane Gingras,Annie Karakeussian Rimbaud,Geneviève Marcoux,Crysta Spino,Nicolas Thibodeau,Eric Bonneil,Pierre Thibault,Éric Boilard,Mélanie Dieudé,Marie-Josée Hébert

Cell death & disease 12:1149 PubMed34897284

2021

CD82 protects against glaucomatous axonal transport deficits via mTORC1 activation in mice.

Applications

Unspecified application

Species

Unspecified reactive species

Meng Ye,Jingqiu Huang,Qianxue Mou,Jing Luo,Yuanyuan Hu,Xiaotong Lou,Ke Yao,Bowen Zhao,Qiming Duan,Xing Li,Hong Zhang,Yin Zhao

Gastroenterology 159:1019-1035.e22 PubMed32446697

2020

Protein Kinase D1, Reduced in Human Pancreatic Tumors, Increases Secretion of Small Extracellular Vesicles From Cancer Cells That Promote Metastasis to Lung in Mice.

Applications

Unspecified application

Species

Unspecified reactive species

Milena Armacki,Sandra Polaschek,Mareike Waldenmaier,Mareen Morawe,Claudia Ruhland,Rebecca Schmid,André Lechel,Umesh Tharehalli,Christoph Steup,Yasin Bektas,Hongxia Li,Johann M Kraus,Hans A Kestler,Stephan Kruger,Steffen Ormanns,Paul Walther,Tim Eiseler,Thomas Seufferlein

Cells 9: PubMed31936142

2020

Investigating the Potential and Pitfalls of EV-Encapsulated MicroRNAs as Circulating Biomarkers of Breast Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Brian M Moloney,Katie E Gilligan,Doireann P Joyce,Clodagh P O'Neill,Killian P O'Brien,Sonja Khan,Claire L Glynn,Ronan M Waldron,Ciarán M Maguire,Emma Holian,Erin Naughton,Mohamed Elhadi,Andrea B Grealish,Carmel Malone,Emma McDermott,Peter Dockery,Thomas Ritter,Adriele Prina-Mello,Michael J Kerin,Róisín M Dwyer

Cancer science 110:2507-2519 PubMed31215741

2019

Interaction of transforming growth factor-β-Smads/microRNA-362-3p/CD82 mediated by M2 macrophages promotes the process of epithelial-mesenchymal transition in hepatocellular carcinoma cells.

Applications

Unspecified application

Species

Unspecified reactive species

Qinghui Zhang,Feng Huang,Yongliang Yao,Jianjun Wang,Jue Wei,Qiong Wu,Shihao Xiang,Ling Xu
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com